Hsi-Wen Yeh

Hsi-Wen Yeh

Auto-generated profile, based on publicly available information

Hsi-Wen Yeh

Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, New York

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYawdong Lang
Yawdong Lang
HCHsin-Yi Chen
Hsin-Yi Chen
CHChun-Ming Ho
Chun-Ming Ho
JSJou-Ho Shih
Jou-Ho Shih
EHEn-Chi Hsu
En-Chi Hsu
YJYuh-Shan Jou
Yuh-Shan Jou
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide due to metastasis. Paraspeckle component 1 (PSPC1) upregulation has been identified as an HCC pro-metastatic activator associated with poor patient prognosis, but with a lack of targeting strategy. Here, we report that PSPC1, a nuclear substrate of PTK6, sequesters PTK6 in the nucleus and loses its metastasis driving capability. Conversely, PSPC1 upregulation or PSPC1-Y523F mutation promotes epithelial-mesenchymal transition, stemness, and metastasis via cytoplasmic translocation of active PTK6 and nuclear translocation of β-catenin, which interacts with PSPC1 to augment Wnt3a autocrine signaling. The aberrant nucleocytoplasmic shuttling of active PTK6/β-catenin is reversed by expressing the PSPC1 C-terminal interacting domain (PSPC1-CT131), thereby suppressing PSPC1/PTK6/β-catenin-activated metastasis to prolong the survival of HCC orthotopic mice. Thus, PSPC1 is the contextual determinant of the oncogenic switch of PTK6/β-catenin subcellular localizations, and PSPC1-CT131 functions as a dual inhibitor of PSPC1 and PTK6 with potential for improving cancer therapy.

31 July 2025 in Cancer Discovery
Verified
Journal Article
Closed access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression. Significance: Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.

2 December 2025
Verified
Other
Open access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
Cancer cells require substantial metabolic adaptations to metastasize to distant organs, but the metabolites essential for successful colonization remain poorly defined. In this study, we used a mitochondrial metabolomics approach to compare primary and metastatic breast cancer cells. This analysis revealed accumulation of mitochondrial glutathione (GSH) during lung metastasis, driven by elevated expression of SLC25A39, a mitochondrial GSH transporter. Loss of SLC25A39 impairs metastatic colonization in genetic screens, cell line models, and patient-derived xenografts, without affecting primary tumor growth. Mitochondrial GSH import is specifically required during early colonization and functions independently of its canonical antioxidant role. CRISPR activation screens identified ATF4, a stress-induced transcription factor, as a bypass mechanism that restores metastatic potential in SLC25A39-deficient cells. Mechanistically, SLC25A39 is required for optimal ATF4 activation during metastasis and under hypoxia, linking mitochondrial GSH availability to integrated stress response signaling. These findings identify mitochondrial GSH as a necessary and limiting metabolite for metastatic progression.Significance:Mitochondrial GSH import via SLC25A39 is essential for early metastatic colonization in breast cancer, linking metabolic adaptation to stress response signaling. Targeting this pathway may uncover a therapeutic vulnerability specific to metastasis without affecting primary tumor growth.

2 December 2025
Verified
Other
Open access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
Mitochondrial profiling reveals context-specific features of breast cancer cells in primary tumors and metastases

2 December 2025
Verified
Other
Open access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
Primers and DNA oligos used in this study

2 December 2025
Verified
Other
Open access
HYHsi-Wen Yeh
Hsi-Wen Yeh
NDNicole Lauren DelGaudio
Nicole Lauren DelGaudio
BUBeste Uygur
Beste Uygur
AMAlon Millet
Alon Millet
AKArtem Khan
Artem Khan
KBKıvanç Birsoy
Kıvanç Birsoy
ATF4 overexpression bypasses the requirement for mitochondrial GSH during metastasis